ERß expression predicts breast cancer risk in hyperplasia

Regulation of T cells in tissues and tumours

Physical pressure of tumour on healthy cells induces oncogenes

ß1 integrins and DNA repair for radiosensitization of head and neck cancer

Mouse models of lung cancer

'Rewiring' tumour susceptibility

Cured AML patients generate anti-tumour antibodies that kill AML blasts

Monitoring the cancer genome in plasma using circulating tumour DNA

Models and critical preclinical data shaping personal therapy

Combination trial designs: efficient, effective and tolerable regimens

Patient perspectives in precision medicine: 'No innovation about us without us'

Liquid biopsies to track clonal evolution and resistance in mCRC